Aminoglycosides: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
(Text replacement - " amikacin" to " amikacin") |
||
| Line 1: | Line 1: | ||
*Gentamicin, amikacin, streptomycin (either alone or with B-lactam) | *Gentamicin, [[amikacin]], streptomycin (either alone or with B-lactam) | ||
**Serious gram-negative bacillary infections | **Serious gram-negative bacillary infections | ||
***Ill patient with pyelonephritis | ***Ill patient with pyelonephritis | ||
Revision as of 10:18, 3 August 2016
- Gentamicin, amikacin, streptomycin (either alone or with B-lactam)
- Serious gram-negative bacillary infections
- Ill patient with pyelonephritis
- Meningitis (due to Pseudomonas, Acinetobacter)
- Peritoneal Dialysis–Associated Peritonitis
- Bacterial endocarditis?
- Serious gram-negative bacillary infections
- Caution: Use in patients with Myasthenia Gravis, can precipitate crisis
See Also
References
Goodman & Gilman's Pharmacology
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||